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Glycogen is a branched polymer of glucose that
serves as an energy store. Phosphate, a trace con-
stituent of glycogen, has profound effects on
glycogen structure, and phosphate hyperaccumula-
tion is linked to Lafora disease, a fatal progressive
myoclonus epilepsy that can be caused bymutations
of laforin, a glycogen phosphatase. However, little is
known about the metabolism of glycogen phos-
phate. We demonstrate here that the biosynthetic
enzyme glycogen synthase, which normally adds
glucose residues to glycogen, is capable of incorpo-
rating the b-phosphate of its substrate UDP-glucose
at a rate of one phosphate per approximately 10,000
glucoses, in what may be considered a catalytic
error. We show that the phosphate in glycogen is
present as C2 and C3 phosphomonoesters. Since
hyperphosphorylation of glycogen causes Lafora
disease, phosphate removal by laforin may thus be
considered a repair or damage control mechanism.
INTRODUCTION
Glycogen is a branched polymer of glucose that serves as a crit-
ical energy reserve in many cells from bacteria to mammals
(Roach, 2002). It consists of chains of glucose residues con-
nected by a-1,4-glycosidic linkages with a-1,6-glycosidic
linkages forming branch points. Glycogen synthase catalyzes
the formation of the primary polymerizing a-1,4-glycosidic link-
ages by transferring a glucosyl moiety from UDP-glucose to
a nonreducing end of a glycogen molecule with the release of
UDP (Roach, 2002). Our recent research has focused on the
importance of covalently linked phosphate, a minor constituent
of glycogen, of uncertain origin and function (Fontana, 1980;
Lomako et al., 1993, 1994). Muscle glycogen, for example,
contains one phosphate per 600-1500 glucose residues, de-
pending on the species (Tagliabracci et al., 2007, 2008).
Abnormal glycogen phosphorylation is associated with Lafora
disease, an autosomal recessive progressive myoclonus
epilepsy with onset in the teenage years followed by gradual
worsening of neurological symptoms and death usually within274 Cell Metabolism 13, 274–282, March 2, 2011 ª2011 Elsevier Inc.ten years (Andrade et al., 2007; Delgado-Escueta, 2007; Gentry
et al., 2009). A characteristic of Lafora disease is the formation of
Lafora bodies, deposits containing sparsely branched, insoluble
glycogen-like polymers in many tissues, including neurons.
About 50% of Lafora patients have mutations in the EPM2A
gene that encodes laforin (Minassian et al., 1998; Serratosa
et al., 1999), a phosphatase of the dual specificity family, with
a carbohydrate binding module. Laforin is capable of releasing
the phosphate from glycogen (Tagliabracci et al., 2007).
Glycogen from Lafora patients has elevated phosphate (Sakai
et al., 1970; Schnabel and Seitelberger, 1968), as does glycogen
from amousemodel of Lafora disease in which the laforin gene is
deleted (Tagliabracci et al., 2007, 2008). In mice, the hyperphos-
phorylation of glycogen is associated with progressive deteriora-
tion in glycogen structure as judged by its physicochemical
properties, reduced branching frequency, and abnormal appear-
ance by electron microscopy (Tagliabracci et al., 2008). There-
fore, knowing the molecular details of phosphate metabolism
in glycogen is critical to understanding Lafora body formation
and Lafora disease. Prior to initiating this work, we knew only
that the glycogen phosphate could be released by laforin and
that excessive phosphate affected glycogen structure and solu-
bility. Important unanswered questions were how the phosphate
was introduced and where it was attached to glycogen. In this
study, we identify a possible origin of the phosphate, an enzyme
capable of its introduction, the chemistry of the phosphate
linkage and first indications of the substrate specificity of laforin.
RESULTS
Introduction of Phosphate into Glycogen by Glycogen
Synthase
Lomako et al. (1993, 1994) proposed that the phosphate in
glycogen was present as a C6 monoester and as a C1–C6
bridging phosphodiester, and that a distinct, but uncharacter-
ized, glucose-1-phosphate transferase was responsible for the
formation of the phosphodiester by transfer of the b-phosphate
of UDP-glucose with release of UMP (Figure 1A). To pursue the
latter idea, we synthesized [b-32P]UDP-glucose to assay and
purify the proposed glucose-1-phosphate transferase. A mouse
muscle extract was indeed able to transfer 32P from [b-32P]UDP-
glucose to glycogen, consistent with the previous study (Lomako
et al., 1993) (Figure 1B). A parallel incubation with UDP-[14C]
glucose monitored the normal incorporation of glucose into
glycogen by glycogen synthase (Figure 1B). Treatment of the
Figure 1. Glycogen Synthase Incorporates Phosphate into Glycogen from UDP-Glucose
(A) UDP-glucose structure and the glucose-1-phosphate transferase reaction proposed by Whelan (see the main text).
(B) Incorporation of [U-14C]glucose (left) and 32P (right) into glycogen (6.67 mg/ml) catalyzed by muscle extracts from wild-type (WT) mice or mice lacking muscle
glycogen synthase (MGSKO) using UDP-[U-14C]glucose and [b-32P]UDP-glucose, respectively, as glucose donors. Reaction products were separated by
SDS-PAGE, and radioactivity was detected by phosphorimaging. The arrow indicates the bottom of the well where glycogen accumulates, and the arrowhead
indicates the top of the stacking gel where smaller polysaccharides migrate. Some samples were also treated with a-amylase and amyloglucosidase, as indi-
cated, prior to SDS-PAGE. Loss of radioactivity indicates association with polysaccharide.
(C) Time-dependent incorporation of [U-14C]glucose (top) and 32P (bottom) into glycogen (6.67 mg/ml) by purified rabbit muscle glycogen synthase (1 mg/ml).
(D) Quantitation of the phosphorimager data in (C). Different gels were analyzed for 32P and 14C incorporation and the arbitrary units are not comparable.
(E) Labeled glycogen, prepared as in (C), was purified by ethanol precipitation, subjected to treatment with a-amylase and amyloglucosidase, as indicated, and
analyzed as in (B).
(F) Glycogen, prepared as in (C), was purified by ethanol precipitation and subjected to treatment with either catalytically inactive C266S laforin (CS) or active
laforin (WT).
(G) Quantitation of 14C and 32P incorporation into glycogen. Glycogen was synthesized with the indicated source of glycogen synthase and duplicate measure-
ments quantitated as described under the Experimental Procedures.
See also Figure S1.
Cell Metabolism
Glycogen Synthase Introduces Phosphate in Glycogensynthesized glycogen by a combination of the enzymes
a-amylase and amyloglucosidase degrades the polysaccharide
by hydrolyzing a-1,4- and a-1,6-glycosidic linkages so that it
would no longer accumulate at the top of the gel. Both the
14C and 32P signals were reduced to background by glucosidase
treatment, confirming that the radioactivity was associated with
a glucose polysaccharide (Figure 1B).
In an attempt to demonstrate that the activity was distinct from
glycogen synthase, we also analyzed an extract from the muscle
of a genetically modified MGSKO mouse lacking muscle
glycogen synthase (Pederson et al., 2004). The MGSKO extract
transferred little 14C into glycogen, as expected, but unexpect-
edly also little 32P (Figure 1B and Figure S1A available online).
Experiments with extracts of wild-type Saccharomyces cerevi-Cesiae and a gsy1 gsy2 mutant strain that lacks both yeast
glycogen synthase genes gave similar results, with glycogen
phosphorylation comparable to that observed with mouse
muscle and reduced to background in the absence of glycogen
synthase (Figure S1A). We therefore concluded that the principal
activity in cell extracts responsible for 32P incorporation into
glycogen was glycogen synthase.
To address this hypothesis, we first tested glycogen synthase
purified from rabbit muscle (DePaoli-Roach et al., 2003). We
found that glycogen synthase catalyzed the time-dependent
introduction of phosphate from UDP-glucose into glycogen at
a constant relative rate with respect to glucose incorporation
(Figures 1C and 1D and Figure S1B). Again, treatment of
the radioactive product with glucosidases confirmed that thell Metabolism 13, 274–282, March 2, 2011 ª2011 Elsevier Inc. 275
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Figure 2. Purification and Analysis of Phosphorylated Oligosaccha-
rides from Rabbit Muscle Glycogen
(A) MALDI-TOF mass spectrometry of phosphorylated oligosaccharides (frac-
tion V; see Figure S1A) from rabbit muscle glycogen. The spectrum displays
a series of species differing by 162.1 m/z indicative of a mixture of phosphor-
ylated oligosaccharides ranging from 3 hexoses + phosphate to 16 hexoses +
phosphate.
(B) HPAEC analysis of malto-oligosaccharide standards. G1, glucose; G2,
maltose; G3, maltotriose; G4, maltotetraose; G5, maltopentaose; G6, malto-
hexaose; G7, maltoheptaose; G8, maltooctaose.
(C) Phosphorylated oligosaccharides (fraction V) were treated with either cata-
lytically inactive laforin (C266S, black) of active laforin (WT, gray) and analyzed
by HPAEC.
(D) Phosphorylated oligosaccharides were treated with either heat denatured
alkaline phosphatase (inactivated AP, black) or active alkaline phosphatase
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276 Cell Metabolism 13, 274–282, March 2, 2011 ª2011 Elsevier Inc.32P was associated with glycogen (Figure 1E). We repeated the
experiment with recombinant Gsy2p, a yeast glycogen synthase
ortholog produced in Escherichia coli, and recombinant human
muscle glycogen synthase produced by baculoviral expression.
The results were very similar to what was observed with the
rabbit enzyme (Figure S1B). By quantitating the incorporated
radioactivity and knowing the specific radioactivities of the
labeled UDP-glucoses, we determined the relativemolar propor-
tions of phosphate and glucose. From such calculations, one
phosphate was introduced for approximately 10,000 glucose
residues by all three purified glycogen synthases (Figure 1G).
A similar phosphorylation stoichiometry was observed with
extracts of yeast or mouse muscle (Figure 1G). This consistency
might suggest that the frequency of phosphate introduction is
linked to the properties of glycogen synthase itself.
The phosphate incorporated by glycogen synthase could be
released after purification of the 32P-labeled glycogen and treat-
ment with recombinant laforin (Figure 1F). The catalytically inac-
tive C266Smutant was ineffective. As would be expected, laforin
had no effect on the 14C-content of the synthesized glycogen. If
laforin can remove the phosphate from the glycogen, its pres-
ence during synthesis might be expected to reduce phosphory-
lation. Therefore, we compared 32P incorporation by extracts of
muscle from wild-type mice and mice with the laforin gene dis-
rupted (Epm2a/) (Figure S1A). Phosphate incorporation into
glycogen was not increased in the knockout extracts (Fig-
ure S1A). This result suggests that laforin does not act during
the synthesis of glycogen in such experiments, a result consis-
tent with the observation that relative phosphate incorporation
by yeast extracts, which also lack laforin, was similar to that of
muscle. In vivo, either conditions differ such that laforin can act
during synthesis or, alternatively, it acts during glycogen
degradation.
Glycogen Contains C2 and C3 Phosphomonoesters
of Glucose
To explore the chemical nature of the glycogen phosphate,
we analyzed glycogen that was purified from rabbit skeletal
muscle by procedures designed to retain phosphoesters. Such
glycogen was previously shown to be a substrate for laforin
(Tagliabracci et al., 2007). Glycogen was digested with
a-amylase and amyloglucosidase and the resulting phospho-
oligosaccharides purified by anion exchange chromatography,
with recovery of 70% of the phosphate (Figure S2). MALDI
TOF mass spectra were dominated by signals consistent with
the presence of phospho-oligosaccharides, varying from three
hexoses plus a phosphate up to 16 hexoses plus a phosphate
(Figure 2A and Figure S2). By high-performance anion exchange
chromatography (HPAEC), the phospho-oligosaccharides
eluted as a complex cluster of species (Figure 2C and Figure S2)
significantly later than maltooctaose (G8), the longest oligosac-
charide standard (Figure 2B), indicating the absence of linear
neutral glucose oligomers smaller than G8. Although the(AP, gray) and analyzed by HPAEC. The asterisks mark species generated
by laforin or alkaline phosphatase treatment that do not align with any of the
linear oligosaccharide standards (B) and that are likely branched oligosaccha-
rides.
See also Figure S2.
Table 1. Chemical Shift Assignments of Phosphorylated Oligosaccharides
Residue 1 2 3 4 5 6
Nuclear Overhauser
Effect
I t-a-Glc-2-P-(1/?) 1H 5.69 4.00 3.76 3.50 3.69 3.83/3.77 –
I t-a-Glc-2-P-(1/?) 13C 100.0 77.3 74.8 72.0 75.0 63.3 –
II t-a-Glc-(1/4) 1H 5.59 3.58 3.65 3.43 3.66 3.83/3.77 IV-4
II t-a-Glc-(1/4) 13C 101.3 74.2 75.4 72.1 75.4 63.3 –
III 4-a-Glc-(1/4) 1H 5.40 3.60 3.97 3.64 3.84 3.83/3.77 IIIn-1-4
a
III 4-a-Glc-(1/4) 13C 102.2 74.1 76.0 79.7 73.8 63.3 –
IV 4-a-Glc-3-P-(1/4) 1H 5.35 3.75 4.46 3.81 3.87 n.d. III-4, VII-4, or VIII-4
IV 4-a-Glc-3-P-(1/4) 13C 102.4 74.6 79.9 76.4 73.8 n.d. –
V 4,6-a-Glcred
1H 5.22 3.55 3.96 3.64 3.93 3.98/3.83 –
V 4,6-a-Glcred
13C 94.6 74.2 76.0 79.7 72.7 69.7 –
VI t-a-Glc-(1/6) 1H 4.99 3.54 3.74 3.44 3.86 n.d. –
VI t-a-Glc-(1/6) 13C 101.5 74.7 74.2 72.1 73.8 n.d. –
VII 4-a-Glc-(1/6) 1H 4.95 3.59 4.01 3.63 3.85 n.d. –
VII 4-a-Glc-(1/6) 13C 100.7 74.1 73.0 80.6 74.0 n.d. –
VIII 4,6-b-Glcred
1H 4.65 3.25 3.77 3.62 3.60 3.97/3.73 –
VIII 4,6-b-Glcred
13C 98.5 76.7 78.9 80.6 77.3 68.8 –
Data from Figure 3 and Figure S3 are collated in the table. n.d., not determined. See also Table S1.
a The next residue in the chain.
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Glycogen Synthase Introduces Phosphate in Glycogenphospho-oligosaccharide mixture is heterogeneous in terms of
polymerization state, it is homogeneous in the sense that it
consists of glucose and glucose-phosphate residues. It was
therefore amenable to analysis by NMR spectroscopy. Several
spin systems were detected by 1H-1H COSY, TOCSY, and
1H-13C HSQC (see Figure S3 and Table 1). The spectra were
dominated by a group of similar spin systems belonging to 4-
a-Glc-(1/4) residues. Other spin systems present included
those of 4-a-Glc-(1/6), terminal a-Glc-(1/4), terminal a-Glc-
(1/6), and a and b reducing end residues that appeared to
be mostly 4,6-linked (i.e., a branching residue glycosylated in
both the 4 and the 6 positions), judging by their H-1 chemical
shifts (van Leeuwen et al., 2008). In addition, two spin systems
were identified, each with one proton resonance uncharacteris-
tically far downfield for glucose, suggesting substitution by
phosphate (Figure S3 and Table S1). On the basis of the connec-
tivities established by the COSY, TOCSY, and ROESY experi-
ments and the carbon chemical shifts determined by the
HSQC experiment, one of these downfield signals appeared to
be H-2 of a terminal glucose residue and the other H-3 of
a 4-linked glucose. To confirm substitution by phosphate,
we acquired a 1H-31P gHMQC spectrum, which showed two
peaks, indicating substitution at the 2-OH and the 3-OH posi-
tions of glucose by phosphate (Figure 3A). We also acquired
a 1H-31P HMQC-TOCSY spectrum to ascertain that these
two protons belong to the spin systems previously assigned.
This spectrum showed the expected correlations of each of
the peaks detected in gHMQC with their neighboring protons
(Figure 3B). From these experiments, therefore, the phosphate
present in muscle glycogen appears to be in the form of C2
and C3 monoesters. We found no evidence for the presence of
a phosphodiester or a C6 phosphate as had been previously
postulated.CeSubstrate Specificity of Laforin
Laforin was able to dephosphorylate phospho-oligosaccharides
generated from glycogen. HPAEC analysis of laforin reaction
products indicated the generation of maltotriose, maltotetraose,
and maltopentaose (Figures 2B and 2C), as well as three other
prominent species (asterisks), which are likely branched oligo-
saccharides. The release of phosphate by laforin is consistent
with the presence of phosphomonoesters since there is no
evidence in the literature that laforin has phosphodiesterase
activity and it is inactive toward p-nitrophenylphosphocholine
or p-nitrophenyl phenylphosphonate, two common phosphodi-
esterase substrates (V.S.T. and P.J.R., unpublished data). Alka-
line phosphatase treatment yielded similar results to laforin treat-
ment with the important exception that significant amounts of
maltose were also produced (Figure 2D). These results further
argue that phosphate is in a monoester linkage and also demon-
strate the presence of maltose-P, maltotriose-P, maltotetraose-
P, andmaltopentaose-P in themixture. In separate experiments,
we have been unable to demonstrate dephosphorylation of
glucose-1-P, glucose-2-P, or glucose-6-P by laforin (data not
shown). These results provide the first insight into laforin’s selec-
tivity for oligosaccharide substrates; laforin can hydrolyse C2
and C3 phosphomonoesters of glucose in oligosaccharides
with a minimum requirement of a trisaccharide phosphate for
activity.
DISCUSSION
The results of this study expand our understanding of themetab-
olism of the phosphate in glycogen (Figure 4). First, the phos-
phate is present as glucose C2 and C3 monoesters. Glucose
C3 phosphate has been described in plant amylopectin (Blen-
now et al., 2002), a polymer chemically related to glycogenll Metabolism 13, 274–282, March 2, 2011 ª2011 Elsevier Inc. 277
Figure 3. 1H-31P Correlated NMR Spectra of Phosphorylated Oligo-
saccharides
The spectra were acquired at 25C and 11.7 T with a 1 s relaxation delay and
3.5 kHz spectral width in F2.
(A) The 1H-31P gHMQC spectrum was acquired with an 8.0 kHz spectral width
in F1, 0.4 s acquisition time, 32 increments, and 360 transients per increment.
(B) The 1H-31P HMQC-TOCSY spectrum was acquired with a 3.0 kHz spectral
width in F1, 0.3 s acquisition time, 40ms spinlock time, 24 increments, and 400
transients per increment. Phosphorus decoupling was turned on during acqui-
sition using the GARP-1 decoupling sequence. The signal marked with an
asterisk is probably from a terminal glucose-2-phosphate residue linked in
a different position but could not be clearly identified due to its low abundance.
See also Figure S3.
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Glycogen Synthase Introduces Phosphate in Glycogen(Ball et al., 1996), but as best we can tell there are no confirmed
descriptions of a glucose C2 phosphomonoester in nature.
Some studies of amylopectin (for example, Tabata and Hizukuri,
1971) had raised the possibility of C2 phosphate in starch but
without providing any formal proof. Of course, other modifica-
tions of the C2 position of glucose are known, as in glucosamine
or N-acetyl-glucosamine, and phosphorylation at C2 in fructose
occurs in fructose-2,6-bisphosphate. Second, we propose
a potential origin of the phosphate in glycogen as the b-phos-
phate of UDP-glucose, introduced by the action of glycogen
synthase in a rare but potentially important deviation from its
presumed ‘‘normal’’ reaction. Though we cannot exclude the278 Cell Metabolism 13, 274–282, March 2, 2011 ª2011 Elsevier Inc.existence of other mechanisms for glycogen phosphorylation
in vivo, the action of glycogen synthase has to be considered
a strong candidate since very little phosphate is incorporated
bymuscle extracts lacking glycogen synthase. There are several
examples of enzymes catalyzing reactions not considered to be
their evolved function. For example, many phosphokinase
enzymes catalyze hydrolysis of the cosubstrate ATP (Knowles,
1980). Another instance is the glucosyltransferase glycogenin,
which is capable of hydrolyzing its substrate UDP-glucose to
form UDP and glucose (Hurley et al., 2005). In these cases, the
consequence is an effective waste of metabolic energy. For
glycogen synthase, the alternative reaction would result in phos-
phorylated glycogen.
With knowledge of the chemical nature of the phosphate
present in glycogen, we can begin to formulate mechanisms
by which glycogen synthase may mediate its introduction into
the polysaccharide. Glycogen synthase belongs to the family
of retaining glycosyltransferases (Lairson et al., 2008) and nor-
mally attaches the C1 of the donor glucose from UDP-glucose
to the C4 of a nonreducing end of glycogen, with retention of
the C1 stereochemistry and release of UDP as the leaving group
(Figure 5). Understanding the catalytic mechanism of this class
of enzymes has been challenging, and debate continues as to
whether a two-stage SN2 reaction or a concerted SNi mecha-
nism is operative (Lairson et al., 2008). In either case, the mech-
anism involves reaction of the C1 of the donor monosaccharide
moiety. Though little discussed in recent years, the formation of
cyclic glucose C1 phosphodiesters is supported by a fairly
extensive literature (Khorana et al., 1957; Kokesh et al., 1977,
1978; Nunez and Barker, 1976; Zmudzka and Shugar, 1964).
For example, glucose-1,2-cyclic phosphate can form spontane-
ously from UDP-glucose under appropriate conditions (Paladini
and Leloir, 1952). One potential explanation for the phosphoryla-
tion of glycogen by glycogen synthase would be if UDP-glucose
infrequently breaks down in the enzyme active site to generate
glucose-1,2-cyclic phosphate or glucose-1,3 cyclic phosphate,
which then enters into the normal catalytic reaction, with attack
at C1 now opening the ring to form a phosphoglucose moiety
that is transferred to C4 of the acceptor (Figure 5).
It is possible that the presence of a controlled amount of phos-
phate in glycogen reflects some as-yet-unappreciated meta-
bolic, structural, or functional purpose. Alternatively, phosphate
incorporation into glycogen might result from a catalytic error by
glycogen synthase. If so, it would resemble errors in the
synthesis of other biopolymers like DNA (Kunkel and Bebenek,
2000), RNA (Thomas et al., 1998), and proteins (Zaher and
Green, 2009). These examples involve misincorporation of
a monomeric unit during polymer synthesis directed by
a template, DNA or mRNA, and specialized repair systems
have evolved to improve the fidelity of polymer production.
Estimates of the error rates for single base substitutions by
proofreading-deficient DNA polymerases range from 103 to
106, depending on the specific enzyme (Kunkel and Bebenek,
2000). Phosphate incorporation by glycogen synthase (104)
is in a similar range. Whereas an error in the synthesis of an indi-
vidual protein or RNAmolecule would have limited impact, errors
in DNA sequence are perpetuated and hence must be strictly
suppressed. Similarly, without a mechanism for its removal,
phosphate incorporated into a glycogen molecule would persist
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(AGL).
(B) Glycogen synthase infrequently (1 in10,000) incorporates phosphate residues into glycogen. The kcat values given simply denote the relative rates of glucose
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Glycogen Synthase Introduces Phosphate in Glycogenbecause each molecule undergoes many rounds of partial
degradation and resynthesis. This turnover of glycogen explains
the difference between the rate of phosphate incorporation into
glycogen by glycogen synthase (1 in 10,000 glucoses) and the
higher level of basal phosphorylation of glycogen in tissues (1 in
1500 glucoses in mouse muscle). The latter is a function not only
of the synthetic rates but also of the relative rates of glucose and
phosphate removal from glycogen, mediated by glycogen phos-
phorylase/debranching enzyme and laforin, respectively.
Whether or not glycogen phosphate has a function or is simply
the result of a catalytic error,wedoknow that excessphosphate is
detrimental to glycogen structure. Therefore, we propose that la-
forin serves toprevent overaccumulation of covalent phosphate in
glycogenandcanbeconsideredpart of a repair ordamagecontrol
mechanism, simpler but conceptually not unlike DNA repair. InO
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Cemice, phosphate introduced by glycogen synthase accumulates
to a basal, tolerated level that remains constant from three to
twelve months of age (Tagliabracci et al., 2008). When laforin is
disabled in laforin knockout mice or Lafora patients, however,
excessive phosphorylation of glycogen occurs and is associated
with a progressive deterioration in glycogen structure (Tagliab-
racci et al., 2008), leading ultimately to Lafora disease and its
tragic consequences (Andrade et al., 2007; Delgado-Escueta,
2007; Gentry et al., 2009). It is interesting that, for the most part,
laforin is restricted to vertebrates (Gentry et al., 2007), organisms
with life spans long enough for excessive phosphorylation of
glycogen to have structural and metabolic consequences.
MGSKO mice are disrupted for the GYS1 gene (Pederson
et al., 2004), which encodes the glycogen synthase isoform ex-
pressed in skeletal muscle, heart, brain, and several otherO
OH
OH
OH
O
n
Figure 5. Proposed Mechanism for the Introduc-
tion of Phosphate into Glycogen by Glycogen Syn-
thase
Glycogen synthase normally transfers a glucose residue
from UDP-glucose to form a new a-1,4-glycosidic linkage
with the C4-hydroxyl at the reducing end of a glycogen
chain (pathway c). The proposed phosphorylation
mechanism would involve the formation, in the active site
of glycogen synthase, of either glucose-1,2-cyclic phos-
phate (pathway a) or glucose-1,3-cyclic phosphate
(pathway b). Reaction of the C1 of the cyclic phospho-
diester would result in the transfer of either a glucose-2-
phosphate or a glucose-3-phosphate moiety in an a-1,4-
glycosidic linkage to a reducing end of glycogen.
ll Metabolism 13, 274–282, March 2, 2011 ª2011 Elsevier Inc. 279
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Glycogen Synthase Introduces Phosphate in Glycogentissues. Some 90% of MGSKO mice die perinatally, most likely
due to defects in embryonic cardiac development caused by
the absence of heart glycogen (Pederson et al., 2004). However,
surviving MGSKO mice, which totally lack brain glycogen,
appear normal, have similar exercise capacity as wild-type
animals, and if anything have improved ability to dispose of
glucose (Pederson et al., 2005a, 2005b). Relevant to this
discussion, the MGSKO mice display no obvious neurological
symptoms up to 20 months of age (B.A. Pederson, personal
communication). Therefore, selective inhibition of brain glycogen
synthase might provide a viable therapeutic intervention in La-
fora disease, for which there is currently no effective treatment.
EXPERIMENTAL PROCEDURES
Enzymes
Rabbit muscle glycogen synthase and yeast Gsy2pwere purified as previously
described (Baskaran et al., 2010; DePaoli-Roach et al., 2003). Purified re-
combinant human glycogen synthasemuscle isoform (GYS1) produced by ba-
culoviral expression in insect cells was the generous gift of May Khanna and
Yuichiro Takagi.
Synthesis and Purification of [b32P] UDP-Glucose
[b32P]UDP-glucose was synthesized enzymatically and purified by a modifica-
tion of the method of Dhugga and Ray (1994) as described in Heyen et al.
(2009). In brief, 5 mCi of [g-32P]ATP (3000 Ci/mmol) was converted enzymati-
cally to [b32P]UDP-glucose and bound to activated charcoal to remove
glucose-1P and glucose-6P. Differential elution from the charcoal separated
the [b32P]UDP-glucose from unreacted [g-32P]ATP. The eluate was dried in
a Speed Vac, and the [b32P]UDP-glucose was resuspended in 100–200 ml of
H2O and stored in aliquots at 80C until use.
Phosphorylation of Glycogen with Glycogen Synthase
A reaction mixture consisting of 50 mM Tris-HCl (pH 7.6), 6.7 mg/ml deionized
rabbit liver glycogen, 7.2 mM glucose-6P, 5 mM EDTA, and 1 mM [b32P]UDP-
glucose (50,000–100,000 cpm/pmol) or 1 mM UDP-[U-14C]glucose (500–
2000 cpm/pmol) and 11.2 mg/ml rabbit muscle glycogen synthase,
1.9 mg/ml human glycogen synthase, or 0.6 mg/ml Gys2p was incubated for
the indicated time or, if not stated, 30 min, and terminated either by boiling
in a 100C H2O bath or by the addition of 2 volumes of ethanol. Immediately
before termination of the reaction, KH2PO4 was added to both the
14C and 32P
reactions to a final concentration of 50 mM to reduce background 32P. All
reactions, whether terminated by boiling or ethanol precipitation, were placed
at 20C for a minimum of 1 hr in 66% ethanol containing 5–15 mM LiCl to
precipitate the radiolabeled glycogen. The glycogen was recovered by
centrifugation at 17,500 3 g for 20 min at 4C and dissolved in H2O to a final
concentration of 6.67 mg/ml, and SDS loading buffer was added. After
boiling, the glycogen (200–250 mg) was subjected to SDS-PAGE and the
radioactivity visualized by autoradiography using a phosphorimager. For
quantitation of 32P, the radioactive region was excised from the gel, minced,
and added to scintillation fluid. Background from blank reactions lacking
glycogen synthase were subtracted. For quantitation of 14C, the purified
glycogen was spotted onto filter paper, washed in 66% ethanol, dried, and
added to scintillation fluid. Radioactivity was determined with a scintillation
counter.
Initially, we attempted to adapt the standard glycogen synthase assay
(Thomas et al., 1968) to measure 32P incorporation. In this assay, the reaction
is transferred to filter paper, immersed in 66%ethanol to terminate the reaction
and to remove unreacted UDP-[U-14C]glucose, leaving 14C-labeled glycogen
trapped on the filter paper. However, we discovered that UDP binds signifi-
cantly to the filter papers. With [b32P]UDP-glucose as substrate, the normal
glycogen synthase reaction generates [b32P]UDP which binds to the filter
and gives a false value for the incorporation of 32P.
For some experiments, the glycogen pellet was redissolved in H2O to a final
concentration of 8.3 mg/ml and diluted to 6.7 mg/ml by the addition of
a-amylase and amyloglucosidase (final concentration of 300 mg/ml for each280 Cell Metabolism 13, 274–282, March 2, 2011 ª2011 Elsevier Inc.glucosidase and 20 mM sodium acetate [pH 4.8]) or laforin (see below). The
glucosidase reaction was for a minimum of 1 hr at 37C–40C and was termi-
nated by the addition of SDS loading buffer.
Phosphorylation of Glycogen with Skeletal Muscle or Yeast Extracts
Rabbit liver glycogen was incubated with skeletal muscle extracts from wild-
type or genetically modifiedmice. Frozen tissue samples (30mg) were homog-
enized in 10 volumes (w/v) of a buffer containing 50 mM Tris-HCl (pH 7.8),
10 mM EDTA, 2 mM EGTA, 100 mM NaF, 2 mM benzamidine, 0.1 mM Na-p-
tosyl-L-lysine chloromethyl ketone, 50 mM b-mercaptoethanol, 0.5 mM
PMSF, 10 mg/ml leupeptin with a Tissue Tearer at maximal speed for 20–
30 s. Muscle homogenates were centrifuged at 36003 g and the supernatant
(100 mg of total protein) used to start the reaction as described above.
S. cerevisiae (EG3281A or DH3 gsy1 gsy2 [Cheng et al., 1995]) were grown
on YPD overnight, harvested by centrifugation, and homogenized by agitation
with glass beads in a homogenization buffer as above without EGTA. Low-
speed centrifugation yielded a cell extract used for the assay. After incubation
at 30C for 30 min, the glycogen was purified, treated with or without glucosi-
dases, and visualized as above.
Dephosphorylation of 32P-Labeled Glycogen with Laforin
Phosphorylated glycogen (320–350 mg) was incubated with 50 mg/ml active
wild-type laforin or catalytically inactive C266S laforin in phosphatase buffer
(100 mM sodium acetate, 50 mM bis-Tris, 50 mM Tris-HCl, 2 mM DTT
[pH 6.5]) in a final reaction volume of 50 ml for a minimum of 1.5 hr at 37C.
The reaction was terminated by the addition of SDS loading buffer and sub-
jected to SDS-PAGE and the radiolabeled polysaccharide detected by
a phosphorimager.
Purification of Phosphorylated Oligosaccharides from Rabbit
Skeletal Muscle Glycogen
Rabbit skeletal muscle glycogen was purified as in Tagliabracci et al. (2007).
Approximately 250 mg rabbit skeletal muscle glycogen was digested over-
night at 37C–40C with 300 mg/ml amyloglucosidase and 300 mg/ml
a-amylase containing 1 mM CaCl2, and 10 mM sodium acetate (pH 4.8) in
a 3 ml reaction volume. After digestion, the insoluble glycogenin was
removed by centrifugation at 5000 3 g for 5 min, and the digest was placed
in a boiling H2O bath for 10 min to denature the a-amylase and amylogluco-
sidase. After cooling, the protein was removed by centrifugation, and the
cleared supernatant was added to 2 ml (bed volume) DEAE Sepharose resin
equilibrated with 10 mM sodium acetate (pH 4.8) and incubated overnight
on a Nutator at 4C. The resin was poured into a column and washed
with 20 column volumes of H2O. The anionic species were eluted stepwise
(flow rate of 0.5 ml/min) with 10 mM, 50 mM, 100 mM, 500 mM, and 1 M
ammonium bicarbonate (NH4HCO3). Four mililiters of each concentration
was used, and 1 ml fractions were collected. An aliquot (40–60 ml) of each
fraction was used to measure covalent phosphate with the sensitive
Malachite green method (Hess and Derr, 1975). The remainder was dried
in a Speed Vac and redissolved in 500 ml H2O, and dried further until there
was no visible NH4HCO3. The fractions containing phosphate were dis-
solved in H2O to a final concentration of 1 mM phosphate and stored at
20C until use.
Dephosphorylation of Phosphorylated Oligosaccharides Purified
from Rabbit Skeletal Muscle Glycogen
Phosphorylated oligosaccharides (10 ml, 1 mM with respect to phosphate)
were treated with either wild-type laforin (25 mg/ml) or C266S laforin
(25 mg/ml) in 25 mM sodium acetate (pH 5.5) in a final reaction volume of
20 ml overnight at 37C to ensure completion. The reactions were terminated
by boiling in a 100C H2O bath for 10 min, and the precipitated protein was
removed by centrifugation, filtered, and analyzed as described below.
Analysis of Purified Phosphorylated Oligosaccharides
by High-Performance Anion Exchange Chromatography
Phosphorylated oligosaccharides purified from glycogen were analyzed by
high-performance anion exchange chromatography (HPAEC) with a Dionex
ICS3000 with a PA1 column with pulsed amperometric detection. All samples
were filtered with a spin column before injection into a 25 ml injection loop.
Cell Metabolism
Glycogen Synthase Introduces Phosphate in GlycogenEluent A consisted of 100 mM NaOH, and Eluent B 100 mM NaOH containing
1M sodium acetate. The fractions were eluted with a continuous gradient from
0%–75% of Eluent B over 60 min with a flow rate of 0.25 ml/min. Five to ten
nanomoles of phosphorylated oligosaccharides (based on phosphate concen-
tration) were analyzed. Carbohydrate standards (250 pmoles–2.5 nmoles)
were also analyzed.
Matrix-Assisted Laser Desorption Ionization Time of Flight Mass
Spectrometry Analysis of Phosphorylated Oligosaccharides
An aliquot (2 ml, 1 mM phosphate) of purified phosphorylated oligosaccharides
were analyzed by Matrix-assisted laser desorption ionization time of flight
mass spectrometry (MALDI/TOF-MS). The matrix was 20,40,60-trihydroxyace-
tophenone monohydrate (THAP); 0.5 M THAP in ethanol:0.1 M diammonium
hydrogen citrate in H2O: 2:1 (v/v). The matrix solution (1 ml) was deposited first
on the target followed by an equal volume of the sample. All spectra were ob-
tained with a Microflex LRF (Bruker). MALDI/TOF-MS analysis was performed
in the reflector negative ion mode.
Nuclear Magnetic Resonance Spectroscopy
The phosphorylated oligosaccharides were deuterium exchanged by lyophili-
zation from D2O, dissolved in D2O, and transferred to a nuclear magnetic reso-
nance (NMR) tube with magnetic susceptibility plugs matched to D2O (Shi-
gemi). The pD of the sample was 5.9. Proton-proton and proton-carbon
correlated spectra were acquired on a Varian Inova 600 MHz spectrometer
equipped with a 3 mm cryoprobe or a Varian Inova 800 MHz spectrometer,
equipped with a 5 mm cryoprobe. Proton-phosphorous correlated spectra
were acquired on a Varian Inova 500 MHz spectrometer equipped with an
8 mm XH room-temperature probe. All spectra were taken at 25C. Chemical
shifts were referenced to internal acetone [d(1H) = 2.218 ppm, d(13C) = 33.0
ppm] (Wishart et al., 1995). All experiments except the 1H-31P correlated
spectra were acquired with standard Varian pulse sequences. For 1H-31P
correlated experiments, the regular gHMQC and HMQC-TOCSY experiments
were modified for 31P in the X channel, with a p pulse of 13 ms at a level of 60
dB, and a 3JH-P coupling constant of 7 Hz. Chemical shifts were referenced to
external 85% phosphoric acid [d(31P) = 0.00 ppm]. Additional acquisition
parameters are listed in Table S1.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and one table and can be
found with this article online at doi:10.1016/j.cmet.2011.01.017.
ACKNOWLEDGMENTS
Supported in part by National Institutes of Health (NIH) grants DK27221 and
NS56454 (to P.J.R.), NIH/National Center for Research Resources grant P41
RR018502 to the Complex Carbohydrate Research Center, University of
Georgia, and the American Heart Association (to V.S.T.). We thank Zhong-
Yin Zhang, James Maller, and Nina Raben for comments regarding the
manuscript.
Received: August 24, 2010
Revised: November 8, 2010
Accepted: January 21, 2011
Published: March 1, 2011
REFERENCES
Andrade, D.M., Turnbull, J., and Minassian, B.A. (2007). Lafora disease,
seizures and sugars. Acta Myol. 26, 83–86.
Ball, S., Guan, H.P., James, M., Myers, A., Keeling, P., Mouille, G., Bule´on, A.,
Colonna, P., and Preiss, J. (1996). From glycogen to amylopectin: a model for
the biogenesis of the plant starch granule. Cell 86, 349–352.
Baskaran, S., Roach, P.J., DePaoli-Roach, A.A., and Hurley, T.D. (2010).
Structural basis for glucose-6-phosphate activation of glycogen synthase.
Proc. Natl. Acad. Sci. USA 107, 17563–17568.CeBlennow, A., Nielsen, T.H., Baunsgaard, L., Mikkelsen, R., and Engelsen, S.B.
(2002). Starch phosphorylation: a new front line in starch research. Trends
Plant Sci. 7, 445–450.
Cheng, C., Mu, J., Farkas, I., Huang, D., Goebl, M.G., and Roach, P.J. (1995).
Requirement of the self-glucosylating initiator proteins Glg1p and Glg2p for
glycogen accumulation in Saccharomyces cerevisiae. Mol. Cell. Biol. 15,
6632–6640.
Delgado-Escueta, A.V. (2007). Advances in lafora progressive myoclonus
epilepsy. Curr. Neurol. Neurosci. Rep. 7, 428–433.
DePaoli-Roach, A.A., Vilardo, P.G., Kim, J.H., Mavila, N., Vemuri, B., and
Roach, P.J. (2003). Determination of mammalian glycogen synthase phospha-
tase activity. Methods Enzymol. 366, 17–34.
Dhugga, K.S., and Ray, P.M. (1994). Purification of 1,3-beta-D-glucan syn-
thase activity from pea tissue. Two polypeptides of 55 kDa and 70 kDa copurify
with enzyme activity. Eur. J. Biochem. 220, 943–953.
Fontana, J.D. (1980). The presence of phosphate in glycogen. FEBS Lett. 109,
85–92.
Gentry, M.S., Dowen, R.H., 3rd, Worby, C.A., Mattoo, S., Ecker, J.R., and
Dixon, J.E. (2007). The phosphatase laforin crosses evolutionary boundaries
and links carbohydrate metabolism to neuronal disease. J. Cell Biol. 178,
477–488.
Gentry, M.S., Dixon, J.E., andWorby, C.A. (2009). Lafora disease: insights into
neurodegeneration from plant metabolism. Trends Biochem. Sci. 34, 628–639.
Hess, H.H., and Derr, J.E. (1975). Assay of inorganic and organic phosphorus
in the 0.1-5 nanomole range. Anal. Biochem. 63, 607–613.
Heyen, C.A., Tagliabracci, V.S., Zhai, L., and Roach, P.J. (2009).
Characterization of mouse UDP-glucose pyrophosphatase, a Nudix hydrolase
encoded by the Nudt14 gene. Biochem. Biophys. Res. Commun. 390, 1414–
1418.
Hurley, T.D., Stout, S., Miner, E., Zhou, J., and Roach, P.J. (2005).
Requirements for catalysis in mammalian glycogenin. J. Biol. Chem. 280,
23892–23899.
Khorana, H.G., Tener, R.S., Wright, R.S., and Moffatt, J.G. (1957). Cyclic
Phosphates. III. Some General Observations on the Formation and
Properties of Five-, Six- and Seven-membered Cyclic Phosphate Esters.
J. Am. Chem. Soc. 79, 430–436.
Knowles, J.R. (1980). Enzyme-catalyzed phosphoryl transfer reactions. Annu.
Rev. Biochem. 49, 877–919.
Kokesh, F.C., Stephenson, R.K., and Kakuda, Y. (1977). Inhibition of potato
starch phosphorylase by alpha-D-glucopyranose-1,2-cyclic phosphate.
Biochim. Biophys. Acta 483, 258–262.
Kokesh, F.C., Cameron, D.A., Kauda, Y., and Kuras, P.V. (1978). Hydrolysis of
a-glucopyranose 1,2-cyclic phosphate: the effect of pH and temperature on
the product distribution, and the position of opening of the phosphate diester
ring in formation of D-glucose 2-phosphate. Carbohydr. Res. 62, 289–300.
Kunkel, T.A., and Bebenek, K. (2000). DNA replication fidelity. Annu. Rev.
Biochem. 69, 497–529.
Lairson, L.L., Henrissat, B., Davies, G.J., and Withers, S.G. (2008).
Glycosyltransferases: structures, functions, and mechanisms. Annu. Rev.
Biochem. 77, 521–555.
Lomako, J., Lomako, W.M., Whelan, W.J., and Marchase, R.B. (1993).
Glycogen contains phosphodiester groups that can be introduced by
UDPglucose: glycogen glucose 1-phosphotransferase. FEBS Lett. 329,
263–267.
Lomako, J., Lomako, W.M., Kirkman, B.R., and Whelan, W.J. (1994). The role
of phosphate in muscle glycogen. Biofactors 4, 167–171.
Minassian, B.A., Lee, J.R., Herbrick, J.A., Huizenga, J., Soder, S., Mungall,
A.J., Dunham, I., Gardner, R., Fong, C.Y., Carpenter, S., et al. (1998).
Mutations in a gene encoding a novel protein tyrosine phosphatase cause
progressive myoclonus epilepsy. Nat. Genet. 20, 171–174.
Nunez, H.A., and Barker, R. (1976). The metal ion catalyzed decomposition of
nucleoside diphosphate sugars. Biochemistry 15, 3843–3847.ll Metabolism 13, 274–282, March 2, 2011 ª2011 Elsevier Inc. 281
Cell Metabolism
Glycogen Synthase Introduces Phosphate in GlycogenPaladini, A.C., and Leloir, L.F. (1952). Studies on uridine-diphosphate-glucose.
Biochem. J. 51, 426–430.
Pederson, B.A., Chen, H., Schroeder, J.M., Shou, W., DePaoli-Roach, A.A.,
and Roach, P.J. (2004). Abnormal cardiac development in the absence of heart
glycogen. Mol. Cell. Biol. 24, 7179–7187.
Pederson, B.A., Cope, C.R., Schroeder, J.M., Smith, M.W., Irimia, J.M.,
Thurberg, B.L., DePaoli-Roach, A.A., and Roach, P.J. (2005a). Exercise
capacity of mice genetically lacking muscle glycogen synthase: in mice,
muscle glycogen is not essential for exercise. J. Biol. Chem. 280, 17260–
17265.
Pederson, B.A., Schroeder, J.M., Parker, G.E., Smith, M.W., DePaoli-Roach,
A.A., and Roach, P.J. (2005b). Glucose metabolism in mice lacking muscle
glycogen synthase. Diabetes 54, 3466–3473.
Roach, P.J. (2002). Glycogen and its metabolism. Curr. Mol. Med. 2, 101–120.
Sakai, M., Austin, J., Witmer, F., and Trueb, L. (1970). Studies in myoclonus
epilepsy (Lafora body form). II. Polyglucosans in the systemic deposits of
myoclonus epilepsy and in corpora amylacea. Neurology 20, 160–176.
Schnabel, R., and Seitelberger, F. (1968). Histophysical and histochemical
investigations of myoclonus bodies. Pathol. Eur. 3, 218–226.
Serratosa, J.M., Go´mez-Garre, P., Gallardo, M.E., Anta, B., de Bernabe´, D.B.,
Lindhout, D., Augustijn, P.B., Tassinari, C.A., Malafosse, R.M., Topcu,M., et al.
(1999). A novel protein tyrosine phosphatase gene is mutated in progressive
myoclonus epilepsy of the Lafora type (EPM2). Hum. Mol. Genet. 8, 345–352.
Tabata, S., and Hizukuri, S. (1971). Studies on starch phosphate. Part 2.
Isolation of glucose 3-phosphate and maltose phosphate by acid hydrolysis
of potato starch. Starch-Sta¨rke 23, 267–272.282 Cell Metabolism 13, 274–282, March 2, 2011 ª2011 Elsevier Inc.Tagliabracci, V.S., Turnbull, J., Wang, W., Girard, J.M., Zhao, X., Skurat, A.V.,
Delgado-Escueta, A.V., Minassian, B.A., Depaoli-Roach, A.A., andRoach, P.J.
(2007). Laforin is a glycogen phosphatase, deficiency of which leads to
elevated phosphorylation of glycogen in vivo. Proc. Natl. Acad. Sci. USA
104, 19262–19266.
Tagliabracci, V.S., Girard, J.M., Segvich, D., Meyer, C., Turnbull, J., Zhao, X.,
Minassian, B.A., Depaoli-Roach, A.A., and Roach, P.J. (2008). Abnormal
metabolism of glycogen phosphate as a cause for Lafora disease. J. Biol.
Chem. 283, 33816–33825.
Thomas, J.A., Schlender, K.K., and Larner, J. (1968). A rapid filter paper assay
for UDPglucose-glycogen glucosyltransferase, including an improved biosyn-
thesis of UDP-14C-glucose. Anal. Biochem. 25, 486–499.
Thomas, M.J., Platas, A.A., and Hawley, D.K. (1998). Transcriptional fidelity
and proofreading by RNA polymerase II. Cell 93, 627–637.
van Leeuwen, S.S., Kralj, S., van Geel-Schutten, I.H., Gerwig, G.J., Dijkhuizen,
L., and Kamerling, J.P. (2008). Structural analysis of the alpha-D-glucan
(EPS35-5) produced by the Lactobacillus reuteri strain 35-5 glucansucrase
GTFA enzyme. Carbohydr. Res. 343, 1251–1265.
Wishart, D.S., Bigam, C.G., Yao, J., Abildgaard, F., Dyson, H.J., Oldfield, E.,
Markley, J.L., and Sykes, B.D. (1995). 1H, 13C and 15N chemical shift refer-
encing in biomolecular NMR. J. Biomol. NMR 6, 135–140.
Zaher, H.S., and Green, R. (2009). Fidelity at the molecular level: lessons from
protein synthesis. Cell 136, 746–762.
Zmudzka, B.S., and Shugar, D. (1964). Preparation and chemical and enzymic
properties of cyclic phosphates of D-glucopyranose and synthesis of deriva-
tives of N-(D-glucopyranosyl) pyridine. Acta Biochim. Pol. 11, 509–525.
